本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.6449
-0.0084-1.29%
盤後0.5802-0.0647-10.03%19:56 EDT
成交量:26.58萬
成交額:17.52萬
市值:392.16萬
市盈率:-4.75
高:0.6799
開:0.6550
低:0.6200
收:0.6533
52周最高:2.79
52周最低:0.5700
股本:608.09萬
流通股本:501.95萬
量比:0.73
換手率:5.29%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
淨資產收益率:-1708.61%
總資產收益率:-22.79%
市淨率:0.92
市盈率(LYR):-4.75

資料載入中...

2023/06/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/27

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/12

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses